AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionAspire Private Capital, LLC
Latest Disclosed Ownership9,130 shares
Latest Disclosed Value $ 1,985,633
Aspire Private Capital, LLC reports 12.95% increase in ownership of 4AB / AbbVie Inc.

On April 22, 2026 - Aspire Private Capital, LLC filed a 13F-HR form disclosing ownership of 9,130 shares of AbbVie Inc. (BG:4AB) valued at $1,985,633 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 8,083 shares of AbbVie Inc.. This represents a change in shares of 12.95% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F ABBVIE COM 00287Y109 9,130 1,047 12.95 1,986 7.53 0.2453
2026-01-16 2025-12-31 13F ABBVIE COM 00287Y109 8,083 -214 -2.58 1,847 -3.85 0.4108
2025-11-19 2025-09-30 13F/A-1 ABBVIE COM 00287Y109 8,297 740 9.79 1,921 36.95 0.4222
2025-10-29 2025-09-30 13F ABBVIE COM 00287Y109 7,557 0 1,403 0.2628
2025-07-22 2025-06-30 13F ABBVIE COM 00287Y109 7,557 -415 -5.21 1,403 -16.05 0.3261
2025-04-22 2025-03-31 13F ABBVIE COM 00287Y109 7,972 670 9.18 1,670 28.76 0.4154
2025-01-17 2024-12-31 13F ABBVIE COM 00287Y109 7,302 756 11.55 1,297 0.39 0.3218
2024-10-25 2024-09-30 13F ABBVIE COM 00287Y109 6,546 304 4.87 1,293 20.75 0.3078
2024-07-15 2024-06-30 13F ABBVIE COM 00287Y109 6,242 620 11.03 1,071 4.59 0.2758
2024-04-18 2024-03-31 13F ABBVIE COM 00287Y109 5,622 515 10.08 1,024 29.33 0.2698
2024-02-01 2023-12-31 13F ABBVIE COM 00287Y109 5,107 186 3.78 792 7.91 0.2346
2023-11-03 2023-09-30 13F ABBVIE COM 00287Y109 4,921 80 1.65 734 12.42 0.2391
2023-07-24 2023-06-30 13F ABBVIE COM 00287Y109 4,841 18 0.37 652 -15.10 0.2076
2023-05-30 2023-03-31 13F/A-1 ABBVIE COM 00287Y109 4,823 -458 -8.67 769 -9.96 0.2552
2023-05-03 2023-03-31 13F ABBVIE COM 00287Y109 4,823 -458 768,583 0.2552
2023-05-30 2022-12-31 13F/A-1 ABBVIE COM 00287Y109 5,281 123 2.38 853 23.27 0.3065
2023-02-14 2022-12-31 13F ABBVIE COM 00287Y109 5,281 123 853 0.3065
2022-11-10 2022-09-30 13F ABBVIE COM 00287Y109 5,158 -239 -4.43 692 -16.32 0.2633
2022-08-01 2022-06-30 13F ABBVIE COM 00287Y109 5,397 -84 -1.53 827 -6.97 0.2952
2022-05-10 2022-03-31 13F ABBVIE COM 00287Y109 5,481 -1,441 -20.82 889 -5.12 0.2837
2022-02-14 2021-12-31 13F ABBVIE COM 00287Y109 6,922 175 2.59 937 28.71 0.2928
2021-11-15 2021-09-30 13F ABBVIE COM 00287Y109 6,747 377 5.92 728 1.39 0.2431
2021-08-09 2021-06-30 13F ABBVIE COM 00287Y109 6,370 -672 -9.54 718 -5.77 0.2301
2021-05-26 2021-03-31 13F ABBVIE COM 00287Y109 7,042 -469 -6.24 762 -5.34 0.2668
2021-02-16 2020-12-31 13F AbbVie COM 00287Y109 7,511 -35 -0.46 805 21.79 0.3076
2020-11-13 2020-09-30 13F AbbVie COM 00287Y109 7,546 -15 -0.20 661 -11.04 0.2707
2020-08-13 2020-06-30 13F ABBVIE COM 00287Y109 7,561 -814 -9.72 743 16.46 0.3455
2020-05-14 2020-03-31 13F AbbVie COM 00287Y109 8,375 -537 -6.03 638 -19.14 0.3463
2020-02-11 2019-12-31 13F ABBVIE COM 00287Y109 8,912 -307 -3.33 789 13.04 0.3416
2019-11-12 2019-09-30 13F ABBVIE COM 00287Y109 9,219 845 10.09 698 14.61 0.3317
2019-08-13 2019-06-30 13F ABBVIE COM 00287Y109 8,374 -437 -4.96 609 -14.23 0.2908
2019-05-13 2019-03-31 13F ABBVIE COM 00287Y109 8,811 -71 -0.80 710 -13.31 0.3577
2019-02-25 2018-12-31 13F/A-1 AbbVie Com 00287Y109 8,882 8,882 819 0.4731
2019-02-14 2018-12-31 13F AbbVie Com 00287Y109 888 819
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.